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Although hantaviruses have been previously considered as rodent-borne pathogens, recent studies
demonstrate genetically distinct hantaviruses in evolutionarily distant non-rodent reservoirs, including
shrews, moles and bats. The immunological responses to these newfound hantaviruses in humans are
unknown. We compared the innate immune responses to Imjin virus (MJNV) and Thottapalayam virus
(TPMV), two shrew-borne hantaviruses, with that toward two rodent-borne hantaviruses, pathogenic
Hantann virus (HTNV) and nonpathogenic Prospect Hill virus (PHV). Infection of human macrophages
and endothelial cells with either HTNV or MJNV triggered productive viral replication and up-
regulation of anti-viral responsive gene expression from day 1 to day 3 postinfection, compared with
PHV and TPMV. Furthermore, HTNV, MJNV and TPMV infection led to prolonged increased production
of pro-inﬂammatory cytokines from days 3 to 7 postinfection. By contrast, PHV infection failed to
induce pro-inﬂammatory responses. Distinct patterns of innate immune activation caused by MJNV
suggest that it might be pathogenic to humans.
& 2012 Elsevier Inc. All rights reserved.Introduction
Approximately half of the more than 50 hantavirus species
identiﬁed in multiple rodent species worldwide are pathogenic to
humans (Klein and Calisher, 2007), causing distinct clinical
syndromes known as hemorrhagic fever with renal syndrome
(HFRS) and hantavirus cardiopulmonary syndrome (HCPS). Wide-
spread throughout Asia and Europe, HFRS is characterized by
increased vascular permeability and acute renal insufﬁciency or
failure, whereas HCPS occurs in North and South America with
patients exhibiting mild to severe hypoxemia and respiratory
failure with cardiogenic shock. Hantaan virus (HTNV), Seoul virus
(SEOV) and Puumala virus (PUUV) are the principal HFRS-causing
hantaviruses, whereas Sin Nombre virus (SNV) and Andes virus
(ANDV) are prototypic hantaviruses that cause HCPS. Best known
among the so-called nonpathogenic hantaviruses are Prospect Hill
virus (PHV) and Tula virus (TULV) (Easterbrook and Klein, 2008;
Klein and Calisher, 2007; Markotic, 2003).
Previously, all hantavirus species were believed to be harbored by
rodents. Recent studies, however, indicate that genetically distinct
hantaviruses are also hosted by non-rodent reservoirs, includingll rights reserved.
rtment of Microbiology 5-ga,
Korea. Fax: þ82 2 923 3645.shrews (Arai et al., 2008a; Arai et al., 2012; Arai et al., 2007; Kang
et al., 2011a, 2011b; Song et al., 2007b; Song et al., 2007c, 2009),
moles (Arai et al., 2008b; Kang et al., 2009a, 2011a, 2009b) and bats
(Sumibcay et al., 2012; Weiss et al., 2012). Thottapalayam virus
(TPMV), initially an unclassiﬁed virus isolated from the Asian house
shrew (Suncus murinus) (Carey et al., 1971), is now known to be
among the most genetically and phylogenetically divergent of all
hantaviruses (Song et al., 2007a). Similarly, phylogenetic analysis of
Imjin virus (MJNV), recently isolated from the Ussuri white-toothed
shrew (Crocidura lasiura) (Song et al., 2009), indicates an early
evolutionary divergence from rodent-borne hantaviruses. Although
limited data are available about the pathogenic potential of these
newfound hantaviruses in humans, the detection of anti-TPMV IgG in
a patient with high fever of unknown etiology in Thailand suggests
the possibility that TPMV and other shrew-borne hantaviruses might
cause a wide spectrum of clinical disease (Okumura et al., 2007; Song
et al., 2007a). However, the importance of these and other as yet
uncharacterized hantaviruses as human pathogens requires further
exploration.
Modulation of innate immune responses by rodent-borne hanta-
viruses has been previously described (Easterbrook and Klein, 2008;
Rang, 2010). Both pathogenic and nonpathogenic rodent-borne
hantaviruses were shown to differentially modulate mRNA expres-
sion of genes of both anti-viral and pro-inﬂammatory innate immune
responses in human endothelial cells (Alff et al., 2006; Geimonen
et al., 2002; Handke et al., 2009; Kraus et al., 2004; Spiropoulou et al.,
O.S. Shin et al. / Virology 434 (2012) 43–49442007). Interestingly, a different interferon response was observed at
one day postinfection (p.i.) with either pathogenic (HTNV or NYV) or
putative nonpathogenic (PHV) hantaviruses. PHV infection caused a
more rapid and profound expression of interferon (IFN)-related gene
transcripts, compared with pathogenic hantaviruses. The inhibition
of PHV replication in human endothelial cells suggests that this early
up-regulation of IFN-related genes induced by PHV infection would
have a detrimental effect on viral replication. Thus, the data suggest
that hantavirus pathogenesis and innate immune responses may in
part be determined by viral regulation of cellular IFN responses (Alff
et al., 2006; Geimonen et al., 2002; Handke et al., 2009; Kraus et al.,
2004; Spiropoulou et al., 2007). Presently, it is unknown whether IFN
responses limit MJNV or TPMV infection of human endothelial cells.
In this study, we explored the innate immune responses to
shrew-borne hantaviruses in human umbilical vein endothelial
cells (HUVEC) and a human macrophage cell line (THP-1). Both
MJNV and TPMV replicated and infected HUVEC similar to rodent-
borne pathogenic or nonpathogenic hantaviruses, but not as
efﬁciently as in THP-1 cells. In contrast to PHV, HTNV and MJNV
were shown to differentially up-regulate anti-viral responsive
genes, such as myxovirus resistance protein gene (MxA) and
interferon-b (IFN-b), from day 1 to day 3 p.i. in THP-1 cells.
Similar to the anti-viral responses, HTNV, MJNV and TPMV
induced pro-inﬂammatory cytokine and chemokine production.
Our ﬁndings provide new insights into innate immune activation
by shrew-borne hantaviruses but leave unanswered the patho-
genicity of these newfound, still-orphan viruses.Results
Replication of HTNV, MJNV, TPMV and PHV in HUVEC and THP-1 cells
Both endothelial cells and macrophages are considered to be
major target cells of hantavirus infection (Easterbrook and Klein,
2008). Accordingly, to study the innate immune responses caused
by shrew-borne hantavirus infection in vitro, HUVEC and THP-1,
differentiated into macrophages with the addition of PMA, were
used. HUVEC and THP-1 cells were infected at a multiplicity of
infection (MOI) of 1 with HTNV, MJNV, TPMV and PHV. HTNV,
MJNV, TPMV and PHV antigens could be detected in 90–100% of
HUVEC (day 1 p.i.) and in 40–50% (day 3 p.i.) of differentiatedFig. 1. Hantavirus infection in HUVEC and THP-1 cells. HUVEC (A) and THP-1 cells (B)
24 h (HUVECs) and 72 h (THP-1). Each virus was detected by IFA staining with incubatio
IgG (green) while the corresponding cell nuclei were stained with 40 ,6-diamidino-2-p
references to color in this ﬁgure legend, the reader is referred to the web version of thTHP-1 cells by immunoﬂuorescence staining (Fig. 1A and B).
Microscopic examination of the morphology and viability of
HUVEC and THP-1 cells did not show cytopathic effects at any
time point during the course of infection (data not shown).
Next, the ability of HTNV, MJNV, TPMV and PHV to replicate in
HUVEC and THP-1 cells was determined, using plaque assay. Cells
were infected at an MOI of 0.5 and virus infectivity in cell super-
natants was titered from days 1 to 7 p.i. At 3 to 4 day p.i., the titers
of HTNV and MJNV reached 103 to 105 PFU/mL in HUVEC cells,
whereas the titers of TPMV remained at 101 to 102 PFU/mL. There
was little PHV replication in HUVEC from days 1 to 7 p.i., with
maximal titers of 101 PFU/mL (Fig. 2A). In comparison with HUVEC,
HTNV and MJNV replication in THP-1 cells showed lower efﬁcacy
and slower kinetics, yielding maximal infectivity titers of 103 to
104 PFU/mL after 5 day p.i. (Fig. 2B). TPMV and PHV remained at
101 to 102 PFU/mL in THP-1 cells from days 1 to 7 p.i. These
ﬁndings suggest that MJNV infection led to the highest replication
efﬁciency in both human endothelial cells and macrophages, which
was similar to that of pathogenic HTNV.
We also determined the level of new protein synthesis,
following infection in HUVEC and THP-1. Nucleocapsid protein
expression in HTNV-, MJNV-, TPMV- or PHV-infected HUVEC or
THP-1 cells was measured by Western blot. Whereas HTNV and
MJNV both increased nucleocapsid protein levels since day 1 p.i.
and persisted until day 6 p.i., nucleocapsid protein levels of TPMV
and PHV increased only after day 3 p.i. in THP-1 cells (Fig. 3).
Therefore, these data suggest that protein synthesis of TPMV and
PHV occurs at later time points than that of HTNV or MJNV in
human macrophages.
Anti-viral responses in HUVEC and THP-1 cells infected with
hantaviruses
To analyze the anti-viral responses induced by infection
with various hantaviruses, transcripts for several anti-viral genes
(MxA and IFN-b) were measured using quantitative real-time PCR
(RT-PCR). Either HUVEC or THP-1 cells were infected with HTNV,
MJNV, TPMV or PHV at an MOI of 0.5 and total RNA was isolated
at 1 and 3 day p.i. At day 1 p.i., PHV infection of HUVEC directed a
more rapid increase in MxA gene expression than HTNV (Fig. 4A).
However, MxA mRNA in HTNV-infected cells increased by 880.9-
fold from days 1 to 3, whereas there was only a 7.9-fold increasewere infected with HTNV, MJNV, TPMV or PHV at an MOI of 1.0 and incubated for
n of each virus-speciﬁc antibody followed by an FITC-conjugated anti-mouse or rat
henylindole (DAPI, blue). Original magniﬁcation X400. (For interpretation of the
is article.)
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Fig. 2. Hantavirus replication in HUVEC and THP-1 cells. HUVEC (A) and THP-1
(B) cells were infected with HTNV, MJNV, TPMV or PHV at an MOI of 1.0. Viral
titers in the supernatant of infected cells were analyzed 1 to 7 day postinfection by
a plaque assay. Days postinfection are indicated on the x axis, and titers are
represented as PFU/mL. Error bars represent SD.
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infection caused 19.8-fold and 45.8-fold increase in MxA gene
expression from days 1 to 3, respectively. IFN-bmRNA expression
was also increased from days 1 to 3 p.i. (4.5-fold by HTNV, 2.7-
fold by MJNV, 5.0-fold by TPMV, and 0.4-fold by PHV) (Fig. 4B).
Hantavirus-induced anti-viral responses in THP-1 cells were
also analyzed. The mRNA expression of MxA gene in HTNV, MJNV
or TPMV-infected cells increased sharply from days 1 to 3 p.i.
However, PHV did not induce MxA gene expression in THP-1 cells
(Fig. 4C). IFN-b gene expression in cells infected by HTNV or MJNV
increased from days 1 to 3 p.i., while no signiﬁcant change was
found from days 1 to 3 p.i. in TPMV- and PHV-infected cells
(Fig. 4D). Compared to TPMV or PHV infection, HTNV or MJNV
infection resulted in signiﬁcant increase of IFN-b and MxA gene
expression from days 1 to 3 p.i. in THP-1 cells, and HTNV and
MJNV may similarly regulate early IFN responses during infection.
Hantaviruses direct the production of pro-inﬂammatory cytokines
and chemokines
To investigate the inﬂammatory responses induced by shrew-
borne hantaviruses, Regulated upon Activation, Normal T-cell
Expressed, and Secreted (RANTES) and interferon gamma-induced
protein-10 (IP-10) mRNA triggered in response to hantavirus infec-
tion was determined by quantitative RT-PCR. As previously reported,
the expression of RANTES was differentially induced in response to
HTNV and PHV infection in HUVEC. Although at day 1 p.i., RANTES
expression was higher in PHV-infected cells than in HTNV-infectedcells, at day 3 p.i., HTNV infection resulted in higher RANTES mRNA
expression compared with PHV infection (Fig. 5B). IP-10 mRNA was
not detected with any of the four hantaviruses at 1 day p.i. However,
IP-10 mRNA was increased at 3 day p.i. by 47.9- to 58.3-fold in
samples from either HTNV- or MJNV-infected cells, compared with
1 day p.i. (Fig. 5A). As demonstrated in Fig. 5C, no detectable levels of
IP-10 mRNA was seen with any of the hantaviruses at day 1 p.i. in
THP-1 cells, however, HTNV and MJNV infection induced signiﬁcant
increase in IP-10 mRNA expression by day 3 p.i. However, at 3 day
p.i., IP-10 mRNA was 103-log fold higher in HTNV- or MJNV-infected
cells and only 4-fold higher in PHV-infected cells, compared with
uninfected cells. The maximal expression of RANTES from days 1 to
3 was induced by MJNV infection (Fig. 5D). These data demonstrate
that HTNV and MJNV infection similarly induced signiﬁcantly higher
increases in IP-10 chemokine expression from days 1 to 3, differen-
tially from PHV.
To determine the pro-inﬂammatory cytokine response caused by
shrew-borne hantavirus infection, we also collected supernatant from
cells on days 1 to 7 p.i. and measured levels of tumor necrosis factor-
a (TNF-a), interleukin-1b (IL-1b) and interleukin-8 (IL-8) by ELISA. At
days 1 to 2 p.i., hantavirus-directed responses were similar between
pathogenic and nonpathogenic viruses. However, at days 3 to 4 p.i.,
each hantavirus began to induce unique cellular responses. HTNV
infection gradually increased the protein secretion levels of TNF-a,
IL-8, and IL-1b, peaking at days 3 to 4 p.i. (Fig. 6). Following a similar
pattern, TNF-a and IL-1b production gradually increased in MJNV-
infected samples until day 4 p.i. (compared with earlier time points)
but IL-8 secretion was down-regulated from days 5 to 7. Notably,
TPMV infection caused up-regulation of TNF-a and IL-1b at earlier
time points than HTNV or MJNV, but induction of IL-8 was not seen.
In contrast to these viruses, PHV infection caused relatively static
or down-regulation of all three cytokines, as shown in Fig. 6. Thus,
these data suggest that the induction patterns of pro-inﬂammatory
cytokines/chemokines differ among various hantaviruses.Discussion
Genetically distinct hantaviruses have been found in multiple
small mammal hosts and the identiﬁcation of novel hantaviruses
with host speciﬁcity suggests the need to study the pathogenesis of
these viruses in humans. The pathogenicity and host immune
responses to shrew-borne hantaviruses are unknown. In our study,
we used two cell types (HUVEC and THP-1 cells) to characterize viral
replication and host innate immune responses (anti-viral and
inﬂammatory) caused by pathogenic (HTNV) and nonpathogenic
(PHV) rodent-borne hantaviruses compared with shrew-borne han-
taviruses (MJNV and TPMV). Of the four hantaviruses tested, MJNV
provoked the highest induction of viral replication in both HUVEC
and THP-1 cells. Similar to HTNV, MJNV induced increased expres-
sion of anti-viral responsive genes in a time-dependent manner. In
contrast to PHV, MJNV caused pronounced up-regulation of pro-
inﬂammatory cytokines and chemokines in human macrophages.
Collectively, our ﬁndings indicate that MJNV and possibly other
shrew-borne hantaviruses elicit host responses via mechanisms that
are similar to pathogenic hantaviruses, but markedly differ from
nonpathogenic hantaviruses.
HTNV and MJNV replicated in HUVEC with similar kinetics and
efﬁciency, yielding maximal titers of 104 to 106 PFU/mL within
7 day p.i. Compared with HUVEC, all of the studied hantaviruses
replicated less productively in THP-1 cells, since viral titers
ranged from 101 to 103 PFU/mL for HTNV and 102 to 104 PFU/mL
for MJNV within the examined timeframe. Both TPMV and PHV
failed to replicate as efﬁciently as HTNV or MJNV, reaching titers
of only 101 to 102 PFU/mL. TPMV and PHV replicated less
efﬁciently than HTNV and MJNV in both HUVEC and THP-1 cells.
Fig. 3. Western blot analysis of N protein expression. HUVEC or THP-1 cells
were infected with HTNV, MJNV, TPMV or PHV (MOI of 1.0). Cells were lysed at 1,
3, 6 day postinfection as indicated. Total protein levels were determined, and an
equivalent amount of whole-cell lysate was separated by 10% SDS-polyacrylamide
gel electrophoresis. Proteins were detected by Western blotting using. Anti-
nucleocapsid monoclonal mouse or polyclonal rat antibody, followed by HRP-
conjugated species-speciﬁc secondary antibodies. Anti-GAPDH monoclonal anti-
body was used as a loading control.
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pared to PHV and TPMV, suggests that MJNV might be a human
pathogen. On the other hand, the absence of replication by TPMV
in these cells also suggests that it may be nonpathogenic like PHV,
which similarly is unable to productively replicate in HUVEC and
THP-1. Furthermore, this differential viral replication pattern may
explain the differential innate immune responses triggered by
these viruses.
Our data indicate that MJNV triggered distinct activation of
innate immune responses, resembling that of the HTNV-speciﬁc
induction pattern, in human macrophages. Using primary human
endothelial cells, several groups have shown that infection with
pathogenic and nonpathogenic hantaviruses differentially acti-
vate the innate IFN system (Alff et al., 2006; Geimonen et al.,
2002; Handke et al., 2009; Kraus et al., 2004; Spiropoulou et al.,
2007). For THP-1 cells, more pronounced increase in expression of
MxA was observed with HTNV, MJNV and TPMV infection from
days 1 to 3 p.i., compared with PHV infection (Fig. 4C). This
observation suggests that high-level replication achieved by
MJNV at earlier time frames might have possibly suppressed
early detection of viruses by unidentiﬁed receptor(s), required for
the activation of innate IFN responses.
Immediately after viral infection, innate antiviral and inﬂam-
matory responses can be elicited. Our data reveal that beyond
anti-viral genes, shrew-borne hantaviruses differentially induce
inﬂammatory responses in THP-1 cells, as indicated by the
expression pattern of IP-10 and RANTES, which are known to
mobilize and attract mononuclear cells, including lymphocytes
and cytokines/chemokines, TNF-a, IL-8 and IL-1b. Compared withPHV, MJNV induced increased expression of both IP-10 and
RANTES with higher kinetics at 3 day p.i. (Fig. 5C and D).
A similar induction pattern of increased TNF-a, IL-8 and IL-1b
production was also observed with MJNV infection whereas PHV
infection failed to cause an increase in cytokine production
(Fig. 6). This suggests that differential virus replication might
drive differential induction of cellular antiviral and proinﬂamma-
tory responses. Our data indicate that hantaviruses, which repli-
cate to higher levels in endothelial cells and macrophages (HTNV
and MJNV), also cause more increased induction of antiviral and
proinﬂammatory responses.
Although MJNV infection has not been reported in humans, it
may be premature to conclude that MJNV is nonpathogenic. In a
recently developed hamster model of MJNV infection, an apparent
age-dependent susceptibility and fatal disease were noted, akin to
an HCPS-like disease caused by ANDV (Gu et al. manuscript
submitted). Thus, in line with our in vitro data, the hamster
model of MJNV infection raises the possibility that MJNV may
cause an immunopathogenesis-driven disease in humans.
Recent discovery of shrew-, mole- and bat-borne hantaviruses
raise important questions about their phylogenetic origin and
potential pathogenicity (Carey et al., 1971; Jung and Kim, 1995;
Song et al., 2007a, 2009, 2007c; Sumibcay et al., 2012; Weiss
et al., 2012). Cross-reactivity between routinely used rodent-
borne hantavirus antigens has been a limiting factor to identifying
patients suffering from clinical diseases possibly caused by novel
hantaviruses. The development of sensitive and speciﬁc serologi-
cal assays for newfound hantaviruses will facilitate future studies
aimed at identifying clinical diseases or syndromes associated
with these viruses.
In conclusion, our study constitutes the ﬁrst attempt to character-
ize the innate immune responses induced by shrew-borne hanta-
viruses. Although cellular receptors for MJNV and TPMV have not
been identiﬁed, either or both might use avb3 integrin receptors,
previously reported as receptors for pathogenic HTNV (Gavrilovskaya
et al., 1998; Mackow and Gavrilovskaya, 2001). Taken together, our
data suggest that shrew-borne hantaviruses differentially induce
anti-viral and pro-inﬂammatory innate immune responses, compared
with nonpathogenic PHV. Further elucidation of the molecular
mechanisms and viral determinants of pronounced immune
responses by shrew-borne hantaviruses would lead to a better
understanding of hantavirus pathogenesis in humans.Materials and methods
Cells and reagents
Vero E6 (African green monkey epithelial kidney cell, ATCC)
were maintained in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM;
Lonza, Walkersville, MD) with 5% heat-inactivated fetal bovine
serum (FBS) (Lonza), 2 mM L-glutamine and antibiotics (penicil-
lin-streptomycin) at 37 1C at 5% CO2. Induced pluripotent stem
cell (iPS) HUVEC were purchased from Inopharmascreen (Asan,
Korea) and maintained in M199 (Gibco), containing penicillin-
streptomycin, 25 mM HEPES, 10 unit/mL heparin, 2.2 g/L sodium
bicarbonate, 20% FBS/ bFGF 20 ng/mL and passaged up to seven
times. The human monocytic cell line THP-1, obtained from the
Korean Cell Line Bank (KCLB) (Seoul, Korea), was grown in RPMI-
1640 (Lonza) supplemented with 5% FBS, 10 mM HEPES buffer,
2 mM L-glutamine, and 50 ng/mL gentamicin. To induce monocyte-
to-macrophage differentiation, THP-1 cells were cultured for 24 h
in standard culture medium supplemented with 100 nM phorbol
12-myristate 13-acetate (PMA; Sigma-Aldrich).
Fig. 4. Kinetics of MxA and IFN-b mRNA induction during hantavirus infection. HUVEC or THP-1 cells were infected with HTNV, MJNV, TPMV or PHV (MOI of 0.5) or
mock infected. RNA was collected at days 1 and 3 postinfection. The mRNA expression of MxA (A) and IFN-b (B) in HUVEC or MxA (C) and IFN-b (D) in THP-1 cells treated
with media was arbitrarily set to 1 and relative expression (log) is shown in the graph. Expression of target genes was normalized to that of b-actin. The qRT-PCR
experiments were performed in duplicate and the average of all experiments is shown. Two-way ANOVA with repeated measures, followed by Bonferroni post-test,
(*po0.05, **po0.01, ***po0.001, 1 day p.i. vs 3 day p.i.). Error bars indicate SD. MxA HUVEC: HTNV po0.001, MJNV po0.01, TPMV p40.05, PHV p40.05; IFN-b HUVEC:
HTNV po0.001, MJNV po0.05, TPMV p40.05, PHV po0.05; MxA THP-1: HTNV po0.001, MJNV po0.001, TPMV p40.05, PHV p40.05; IFN-b THP-1: HTNV po0.001,
MJNV po0.001, TPMV p40.05, PHV p40.05.
Fig. 5. Kinetics of chemokine (IP-10 and RANTES) mRNA expression during hantavirus infection. HUVEC or THP-1 cells were infected with HTNV, MJNV, TPMV or PHV
(MOI of 0.5) or mock infected. RNA was collected at days 1 and 3 postinfection. mRNA expression of IP-10 (A) and RANTES (B) in HUVEC or IP-10 (C) and RANTES (D) in
THP-1 cells treated with media was arbitrarily set to 1 and relative expression (log) is shown in the graph. Expression of target genes was normalized to that of b-actin. The
qRT-PCR experiments were performed in duplicate and the average of all experiments is shown. Two-way ANOVA with repeated measures, followed by Bonferroni post-
test (*po0.05, **po0.01, ***po0.001, 1 day p.i. vs 3 day p.i.). Error bars indicate SD. IP-10 HUVEC: HTNV po0.05, MJNV po0.001, TPMV p40.05, PHV p40.05; RANTES
HUVEC: HTNV po0.001, MJNV po0.001, TPMV p40.05, PHV po0.05; IP-10 THP-1: HTNV po0.001, MJNV po0.001, TPMV p40.05, PHV p40.05; RANTES THP-1: HTNV
p40.05, MJNV po0.001, TPMV po0.05, PHV po0.01.
O.S. Shin et al. / Virology 434 (2012) 43–49 47
Fig. 6. Pro-inﬂammatory cytokine response during hantavirus infection. THP-
1 cells were infected with HTNV, MJNV, TPMV or PHV (MOI of 0.5) or mock
infected (M). Supernatant was collected from days 1 to 7 postinfection. Concen-
trations of TNF-a (A), IL-8 (B) and IL-1b (C) were measured by ELISA. The graph
shows the average of all experiments. Error bars represent SDs.
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HTNV (strain 76-118), TPMV (strain VRC 66412) and PHV
(strain PHV-1) were propagated in Vero E6 cells (Shim et al.,
2011). MJNV strains 04–55 and 05–11 were isolated directly from
shrew lung tissues in Vero E6 cells (Song et al., 2009). Using PCR
analysis, all virus stocks and cells were determined to be free of
mycoplasma contamination.Virus infection and plaque assay
Various cells were infected with each virus at MOI of 0.5
(or 1.0 for immunoﬂuorescence staining, plaque assay and
Western blotting) for 90 min at 37 1C. After incubation, the
viruses were washed in phosphate buffered saline (PBS), and
the cells were maintained in complete medium. Virus infectivity
titers were measured on each postinfection day, using the plaque
assay (Shim et al., 2011).Western blot analysis
Western blot analysis was performed as previously described
(Alff et al., 2006). Brieﬂy, hantavirus-infected HUVEC or THP-1 cells
were lysed as previously described at various times p.i. Cellular
lysates were prepared by lysis buffer (0.05 M Tris pH 7.4, 0.15 M
NaCl, 0.5 mM PMSF, 50 mg/mL aprotinin, 10 mg/mL leupeptin, 50 mg/
mL pepstatin, 0.4 mM sodium orothovanadate, 10 mM sodium
ﬂuoride and 10 mM sodium pyrophosphate) and then separated
by SDS-PAGE on 10% acrylamide gels and transferred to a poly-
vinyldiﬂuoride (PVDF) membrane. The membrane was incubated in
blocking buffer (5% milk in 0.2 M Tris base, 1.36 M NaCl with 0.1%
Tween 20) (TBS/T) for 1 h at room temperature and washed three
times for 5 min each with 15mL of TBS/T. Nucleocapsid proteins
were detected using mouse or rat anti-nucleocapsid sera (1:2,000)
followed by anti-mouse or rat HRP-conjugated antibody (1:5,000)
(Amersham). Membranes were incubated with the primary and
secondary antibodies, respectively, each for 1 h each at 25 1C. Anti-
GAPDH antibody, which served as an internal control, was pur-
chased from Santa Cruz Biotechnology. After washing three times
with TBS/T, the membranes were incubated with HRP-conjugated
anti-rabbit IgG for 1 h at 25 1C. After washing three times with
TBS/T, the membrane was incubated with LumiGLO substrate
(Cell Signaling) and exposed to the ﬁlm.
ELISA
TNF-a, IL-1b and IL-8 were each analyzed in culture media
samples using commercial enzyme-linked immunosorbent assays
(ELISA), according to the manufacturer’s protocols (R&D Systems).
Immunoﬂuorescence microscopy
Various cells were plated in a 24-well plate containing cover-
slips. The following day, cells were infected with each hantavirus
at an MOI of 1.0 for 90 min at 37 1C. Thereafter, fresh cell culture
medium was added and incubated for 24–72 h. Virus-infected
cells were ﬁxed and permeabilized in methanol for 30 min. For
HTNV and MJNV, infected cells were then stained with mouse
monoclonal antibody to HTNV and MJNV, respectively (1:1,000
dilution), and were stained with FITC-conjugated anti-mouse IgG
(HþL) (Vector Laboratories, Burlingame, CA) that served as a
secondary antibody (1:200 dilution). For TPMV and PHV, infected
cells were stained with rat polyclonal antibody to TPMV and PHV,
respectively (1:1,000 dilution), and were stained with FITC-
conjugated anti-rat IgG (HþL) (Vector Laboratories) that was
used as a secondary antibody (1:200 dilution). All antibodies were
diluted in PBS containing 0.05% Tween-20 and 5% skim milk. The
coverslips were mounted onto glass slides using mounting media
containing 4,6-diamidino-2-phenylindole (DAPI) (Vector Labora-
tories) and were examined with ﬂuorescence microscopy using a
Zeiss Axioplan 2 microscope. Images were captured with a digital
CCD camera (Hamamatsu).
Quantitative real time-PCR (Q-rt-PCR)
RNA was isolated with Trizol reagent (Invitrogen). First-strand
synthesis of cDNA from total RNA was performed using ImProm-II
(Promega) according to the manufacturer’s instructions. Quanti-
ﬁcation of cDNA was performed by qRT-PCR using Sybrgreen PCR
mix (Applied Biosystems). Cycling parameters were 95 1C for
10 min, followed by 40 cycles of 95 1C for 30 s and 60 1C for
1 min. Primers were as follows: MxA 50-CGTGGTGATTTAGCAG-
GAAG-30 and 50-TGCAAGGTGGAGCGATTCTG-30; IFN-b1 50-AAACT-
CATGAGCAG TCTGCA-30 and 50-AGGAGATCTTCAGTTTCGGAGG-30;
RANTES 50-GCTGTCATCCTCATTGCTAC-30 and 50-TCCATCCTAGCTCA-
O.S. Shin et al. / Virology 434 (2012) 43–49 49TCT CCA-30; IP-10 50-CGATTCTGATTTGCTGCCTT-30 and 50-CATTTC-
CTTGCTAACTGCTTTC-30; b-actin 50-CCACACCTTCTACAATGAGCTGCG-
30 and 50-CGGAGTCCATCACGATCCA-30. The speciﬁcity of each reac-
tion was checked by melt curve analysis and by agarose gel electro-
phoresis of PCR products. Expression of target genes was referenced
to expression of b-actin. Calculations of expression were normalized
by using the DCt method where the amount of target, normalized to
an endogenous reference and relative to a calibrator, is given by
2DDCt, where Ct is the cycle number of the detection threshold.
Statistical analysis
qRT-PCR data of all experiments were analyzed using ANOVA
for repeated measures, followed by Bonferroni post-test. Graph-
Pad Prism software was used for statistical analysis of the data.
All data were expressed as mean7SD, and signiﬁcance was set at
po0.05.Acknowledgements
This work was supported in part by U.S. Public Health Service
grant R01AI075057 from the National Institute of Allergy and
Infectious Diseases, National Institutes of Health, and by a Korea
University Grant.
References
Alff, P.J., Gavrilovskaya, I.N., Gorbunova, E., Endriss, K., Chong, Y., Geimonen, E.,
Sen, N., Reich, N.C., Mackow, E.R., 2006. The pathogenic NY-1 hantavirus G1
cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.
J. Virol. 80, 9676–9686.
Arai, S., Bennett, S.N., Sumibcay, L., Cook, J.A., Song, J.W., Hope, A., Parmenter, C.,
Nerurkar, V.R., Yates, T.L., Yanagihara, R., 2008a. Phylogenetically distinct
hantaviruses in the masked shrew (Sorex cinereus) and dusky shrew (Sorex
monticolus) in the United States. Am. J. Trop. Med. Hyg. 78, 348–351.
Arai, S., Gu, S.H., Baek, L.J., Tabara, K., Bennett, S.N., Oh, H.S., Takada, N., Kang, H.J.,
Tanaka-Taya, K., Morikawa, S., Okabe, N., Yanagihara, R., Song, J.W., 2012.
Divergent ancestral lineages of newfound hantaviruses harbored by
phylogenetically related crocidurine shrew species in Korea. Virology 424,
99–105.
Arai, S., Ohdachi, S.D., Asakawa, M., Kang, H.J., Mocz, G., Arikawa, J., Okabe, N.,
Yanagihara, R., 2008b. Molecular phylogeny of a newfound hantavirus in the
Japanese shrew mole (Urotrichus talpoides). Proc. Nat. Acad. Sci. U.S.A. 105,
16296–16301.
Arai, S., Song, J.W., Sumibcay, L., Bennett, S.N., Nerurkar, V.R., Parmenter, C., Cook,
J.A., Yates, T.L., Yanagihara, R., 2007. Hantavirus in northern short-tailed
shrew, United States. Emerg. Infect. Dis. 13, 1420–1423.
Carey, D.E., Reuben, R., Panicker, K.N., Shope, R.E., Myers, R.M., 1971. Thottapa-
layam virus: a presumptive arbovirus isolated from a shrew in India. Indian J.
Med. Res. 59, 1758–1760.
Easterbrook, J.D., Klein, S.L., 2008. Immunological mechanisms mediating hanta-
virus persistence in rodent reservoirs. PLoS Pathog. 4, e1000172.
Gavrilovskaya, I.N., Shepley, M., Shaw, R., Ginsberg, M.H., Mackow, E.R., 1998.
beta3 Integrins mediate the cellular entry of hantaviruses that cause respira-
tory failure. Proc. Nat. Acad. Sci. U.S.A. 95, 7074–7079.Geimonen, E., Neff, S., Raymond, T., Kocer, S.S., Gavrilovskaya, I.N., Mackow, E.R.,
2002. Pathogenic and nonpathogenic hantaviruses differentially regulate
endothelial cell responses. Proc. Nat. Acad. Sci. U.S.A. 99, 13837–13842.
Handke, W., Oelschlegel, R., Franke, R., Kruger, D.H., Rang, A., 2009. Hantaan
virus triggers TLR3-dependent innate immune responses. J. Immunol. 182,
2849–2858.
Jung, Y.T., Kim, G.R., 1995. Genomic characterization of M and S RNA segments of
hantaviruses isolated from bats. Acta Virol. 39, 231–233.
Kang, H.J., Bennett, S.N., Dizney, L., Sumibcay, L., Arai, S., Ruedas, L.A., Song, J.W.,
Yanagihara, R., 2009a. Host switch during evolution of a genetically distinct
hantavirus in the American shrew mole (Neurotrichus gibbsii). Virology 388,
8–14.
Kang, H.J., Bennett, S.N., Hope, A.G., Cook, J.A., Yanagihara, R., 2011a. Shared
ancestry between a newfound mole-borne hantavirus and hantaviruses
harbored by cricetid rodents. J. Virol. 85, 7496–7503.
Kang, H.J., Bennett, S.N., Sumibcay, L., Arai, S., Hope, A.G., Mocz, G., Song, J.W.,
Cook, J.A., Yanagihara, R., 2009b. Evolutionary insights from a genetically
divergent hantavirus harbored by the European common mole (Talpa
europaea). PLoS One 4, e6149.
Kang, H.J., Kadjo, B., Dubey, S., Jacquet, F., Yanagihara, R., 2011b. Molecular
evolution of azagny virus, a newfound hantavirus harbored by the
West African pygmy shrew (Crocidura obscurior) in Cote d’Ivoire. Virol. J. 8,
373.
Klein, S.L., Calisher, C.H., 2007. Emergence and persistence of hantaviruses. Curr.
Top. Microbiol. Immunol. 315, 217–252.
Kraus, A.A., Raftery, M.J., Giese, T., Ulrich, R., Zawatzky, R., Hippenstiel, S., Suttorp,
N., Kruger, D.H., Schonrich, G., 2004. Differential antiviral response of
endothelial cells after infection with pathogenic and nonpathogenic hanta-
viruses. J. Virol. 78, 6143–6150.
Mackow, E.R., Gavrilovskaya, I.N., 2001. Cellular receptors and hantavirus patho-
genesis. Curr. Top. Microbiol. Immunol. 256, 91–115.
Markotic, A., 2003. [Immunopathogenesis of hemorrhagic fever with renal
syndrome and hantavirus pulmonary syndrome]. Acta medica Croatica:
casopis Hravatske akademije medicinskih znanosti 57, 407–414.
Okumura, M., Yoshimatsu, K., Kumperasart, S., Nakamura, I., Ogino, M., Taruishi,
M., Sungdee, A., Pattamadilok, S., Ibrahim, I.N., Erlina, S., Agui, T., Yanagihara,
R., Arikawa, J., 2007. Development of serological assays for Thottapalayam
virus, an insectivore-borne hantavirus. Clin. Vaccine Immunol. 14, 173–181.
Rang, A., 2010. Modulation of innate immune responses by hantaviruses. Crit. Rev.
Immunol. 30, 515–527.
Shim, S.H., Park, M.S., Moon, S., Park, K.S., Song, J.W., Song, K.J., Baek, L.J., 2011.
Comparison of innate immune responses to pathogenic and putative non-
pathogenic hantaviruses in vitro. Virus Res. 160, 367–373.
Song, J.W., Baek, L.J., Schmaljohn, C.S., Yanagihara, R., 2007a. Thottapalayam virus,
a prototype shrewborne hantavirus. Emerg. Infect. Dis. 13, 980–985.
Song, J.W., Gu, S.H., Bennett, S.N., Arai, S., Puorger, M., Hilbe, M., Yanagihara, R.,
2007b. Seewis virus, a genetically distinct hantavirus in the Eurasian common
shrew (Sorex araneus). Virol. J. 4, 114.
Song, J.W., Kang, H.J., Gu, S.H., Moon, S.S., Bennett, S.N., Song, K.J., Baek, L.J., Kim,
H.C., O’Guinn, M.L., Chong, S.T., Klein, T.A., Yanagihara, R., 2009. Characteriza-
tion of Imjin virus, a newly isolated hantavirus from the Ussuri white-toothed
shrew (Crocidura lasiura). J. Virol. 83, 6184–6191.
Song, J.W., Kang, H.J., Song, K.J., Truong, T.T., Bennett, S.N., Arai, S., Truong, N.U.,
Yanagihara, R., 2007c. Newfound hantavirus in Chinese mole shrew, Vietnam.
Emerg. Infect. Dis. 13, 1784–1787.
Spiropoulou, C.F., Albarino, C.G., Ksiazek, T.G., Rollin, P.E., 2007. Andes and
prospect hill hantaviruses differ in early induction of interferon although both
can downregulate interferon signaling. J. Virol. 81, 2769–2776.
Sumibcay, L., Kadjo, B., Gu, S.H., Kang, H.J., Lim, B.K., Cook, J.A., Song, J.W.,
Yanagihara, R., 2012. Divergent lineage of a novel hantavirus in the banana
pipistrelle (Neoromicia nanus) in Cote d’Ivoire. Virol. J. 9, 34.
Weiss, S., Witkowski, P.T., Auste, B., Nowak, K., Weber, N., Fahr, J., Mombouli, J.V.,
Wolfe, N.D., Drexler, J.F., Drosten, C., Klempa, B., Leendertz, F.H., Kruger, D.H.,
2012. Hantavirus in bat, Sierra Leone. Emerg. Infect. Dis. 18, 159–161.
